Clinical Trials Directory

Trials / Completed

CompletedNCT01902316

Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus

Clinical Verification for Early Diagnosis of Type 2 Diabetes Mellitus by Standard-Free, Label-Free LC-MS/MS Quantification of Glycated Peptides

Status
Completed
Phase
Study type
Observational
Enrollment
389 (actual)
Sponsor
Beijing Institute of Technology · Academic / Other
Sex
All
Age
35 Years – 72 Years
Healthy volunteers
Accepted

Summary

Although diabetes has been controlled since insulin became available, it is still considered incurable and poses serious threats to human health. Reports have suggested that the hyperglycemic condition of patients with diabetes mellitus may be greatly alleviated or even reversed if it could be controlled at an early stage of diabetes. Thus, early detection and diagnosis of diabetes and prediabetes are become increasingly important in the treatment and prevention of diabetes. Diabetes mellitus is currently diagnosed by recurrent or persistent hyperglycemia. In an effort to identify novel biomarkers for diabetes, research has shown that neither plasma glucose nor glycated hemoglobin (HbA1c) levels are unable to be used in the early detection of diabetes. In this work, the investigators have found 8 biomarker candidates by developing a standard-free, label-free MS-based proteomics method based on standard protein (human serum albumin, the highest abundance protein in human plasma) model in vitro. Then, the investigators wanted to verify these biomarker candidates by clinical plasma samples to see if there is significant quantitative difference between normal people and diabetes patients.

Detailed description

The procedure of clinical study was: 1. to get plasma samples from hospital; 2. digestion of plasma protein-mixture by trypsin; 3. run mass spectrometry and monitor the amount of target HSA-peptides.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2013-07-18
Last updated
2013-07-18

Source: ClinicalTrials.gov record NCT01902316. Inclusion in this directory is not an endorsement.